EMA empfiehlt Zulassung von Ponesimod
Crossref DOI link: https://doi.org/10.1007/s15202-021-4687-5
Published Online: 2021-06-10
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2021-06-01
Version of Record valid from 2021-06-01
Article History
First Online: 10 June 2021
Free to read: This content has been made available to all.